mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.7 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.7 |